1. Home
  2. ASND vs CRS Comparison

ASND vs CRS Comparison

Compare ASND & CRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASND
  • CRS
  • Stock Information
  • Founded
  • ASND 2006
  • CRS 1910
  • Country
  • ASND Denmark
  • CRS United States
  • Employees
  • ASND N/A
  • CRS N/A
  • Industry
  • ASND Biotechnology: Pharmaceutical Preparations
  • CRS Steel/Iron Ore
  • Sector
  • ASND Health Care
  • CRS Industrials
  • Exchange
  • ASND Nasdaq
  • CRS Nasdaq
  • Market Cap
  • ASND 7.7B
  • CRS 8.9B
  • IPO Year
  • ASND 2015
  • CRS N/A
  • Fundamental
  • Price
  • ASND $140.30
  • CRS $172.53
  • Analyst Decision
  • ASND Strong Buy
  • CRS Buy
  • Analyst Count
  • ASND 13
  • CRS 6
  • Target Price
  • ASND $191.77
  • CRS $153.00
  • AVG Volume (30 Days)
  • ASND 427.4K
  • CRS 640.8K
  • Earning Date
  • ASND 02-05-2025
  • CRS 01-23-2025
  • Dividend Yield
  • ASND N/A
  • CRS 0.46%
  • EPS Growth
  • ASND N/A
  • CRS 108.18
  • EPS
  • ASND N/A
  • CRS 4.49
  • Revenue
  • ASND $365,187,374.00
  • CRS $2,825,400,000.00
  • Revenue This Year
  • ASND $7.33
  • CRS $10.41
  • Revenue Next Year
  • ASND $83.72
  • CRS $7.55
  • P/E Ratio
  • ASND N/A
  • CRS $38.40
  • Revenue Growth
  • ASND 115.54
  • CRS 5.45
  • 52 Week Low
  • ASND $111.09
  • CRS $58.87
  • 52 Week High
  • ASND $161.00
  • CRS $198.24
  • Technical
  • Relative Strength Index (RSI)
  • ASND 63.13
  • CRS 39.76
  • Support Level
  • ASND $128.45
  • CRS $172.66
  • Resistance Level
  • ASND $135.71
  • CRS $196.74
  • Average True Range (ATR)
  • ASND 4.77
  • CRS 5.39
  • MACD
  • ASND 0.65
  • CRS -3.24
  • Stochastic Oscillator
  • ASND 91.99
  • CRS 17.47

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

About CRS Carpenter Technology Corporation

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.

Share on Social Networks: